38666-30-7 Usage
Uses
Used in Pharmaceutical Development:
Imidazo[1,5-a]pyridine, 5,6,7,8-tetrahydro(9CI) is utilized as a key building block in the synthesis of various pharmaceuticals. Its unique structure allows for the development of compounds with specific biological activities, making it a valuable asset in medicinal chemistry.
Used in Agrochemical Synthesis:
In the agrochemical industry, Imidazo[1,5-a]pyridine, 5,6,7,8-tetrahydro(9CI) serves as a crucial component in the creation of pesticides and other agrochemicals. Its incorporation into these products can enhance their effectiveness and selectivity, contributing to more efficient and targeted agricultural solutions.
Used in Organic Synthesis Research:
Imidazo[1,5-a]pyridine, 5,6,7,8-tetrahydro(9CI) is also employed in academic and industrial research settings for the exploration of new organic synthesis pathways and methodologies. Its versatile structure provides a platform for investigating novel reactions and mechanisms, further expanding the understanding of organic chemistry and its applications.
Check Digit Verification of cas no
The CAS Registry Mumber 38666-30-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,6,6 and 6 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 38666-30:
(7*3)+(6*8)+(5*6)+(4*6)+(3*6)+(2*3)+(1*0)=147
147 % 10 = 7
So 38666-30-7 is a valid CAS Registry Number.
38666-30-7Relevant academic research and scientific papers
TYK2 INHIBITORS AND USES THEREOF
-
Paragraph 00792, (2020/06/19)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
BETA CARBOLINES AND USES THEREOF
-
Page/Page column 41, (2009/06/27)
This invention provides beta-carboline compounds of formula I: wherein R1, R2, R3, R4, R5, G, and x are as described in the specification. The compounds are useful for treating cancer and inflammatory disorders.
